A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is the reason for this ongoing pandemic infection diseases termed coronavirus disease 2019 (COVID-19) that has emerged since early December 2019 in Wuhan City, Hubei Province, China. In this century, it is the worst threat to international...

Descripción completa

Detalles Bibliográficos
Autores principales: Rameshrad, Maryam, Ghafoori, Majid, Mohammadpour, Amir Hooshang, Nayeri, Mohammad Javad Dehghan, Hosseinzadeh, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235439/
https://www.ncbi.nlm.nih.gov/pubmed/32430617
http://dx.doi.org/10.1007/s00210-020-01901-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235439/
https://www.ncbi.nlm.nih.gov/pubmed/32430617
http://dx.doi.org/10.1007/s00210-020-01901-6

Ejemplares similares